Grufity logoGrufity logo

Teleflex Inc Stock Research

TFX

232.22USD+6.73(+2.98%)Market Closed

Market Summary

USD232.22+6.73
Market Closed
2.98%

TFX Alerts

TFX Stock Price

TFX RSI Chart

TFX Valuation

Market Cap

10.9B

Price/Earnings (Trailing)

30

Price/Sales (Trailing)

3.9

EV/EBITDA

18.71

Price/Free Cashflow

41.32

TFX Price/Sales (Trailing)

TFX Profitability

EBT Margin

15.98%

Return on Equity

9.03%

Return on Assets

5.24%

Free Cashflow Yield

2.42%

TFX Fundamentals

TFX Revenue

Revenue (TTM)

2.8B

Revenue Y/Y

-0.51%

Revenue Q/Q

10.37%

TFX Earnings

Earnings (TTM)

363.1M

Earnings Y/Y

-38.64%

Earnings Q/Q

-22.87%

Price Action

52 Week Range

182.37355.24
(Low)(High)

Last 7 days

-0.9%

Last 30 days

-8.3%

Last 90 days

-9.8%

Trailing 12 Months

-32.5%

TFX Financial Health

Current Ratio

2.43

Debt/Equity

0.48

Debt/Cashflow

0.26

TFX Investor Care

Dividend Yield

0.59%

Dividend/Share (TTM)

1.36

Shares Dilution (1Y)

0.21%

Diluted EPS (TTM)

7.68

Peers (Alternatives to Teleflex)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
104.1B
18.4B
2.26% 8.00%
44.16
5.64
7.84% 18.25%
84.2B
6.2B
-4.47% -13.27%
63.66
13.53
8.97% -22.43%
69.1B
12.7B
0.59% 12.45%
99.06
5.45
6.68% -32.95%
67.4B
19.0B
-5.16% -6.78%
41.86
3.55
-0.43% -8.78%
49.8B
5.4B
2.41% -25.12%
32.74
9.26
2.86% 1.25%
MID-CAP
7.2T
489.7M
9.34% 31.15%
82.2K
16.8K
106.51% 2464.23%
10.2B
847.1M
-3.64% 34.52%
-5.1K
12.05
13.32% -137.89%
5.2B
1.0B
-11.64% -20.31%
30.19
5.09
6.76% 24.45%
3.5B
410.9M
4.51% -3.13%
-29.82
8.43
27.29% -14.60%
2.7B
801.2M
1.13% -58.87%
-28.25
3.34
14.00% -707.69%
SMALL-CAP
1.7B
138.6M
-15.68% 29.18%
-30.43
12.07
36.62% -10.44%
1.6B
350.9M
10.38% 49.06%
-10.84
4.7
44.26% -5.42%
1.3B
820.0M
-8.35% -12.22%
25.89
1.59
10.13% 701.59%
828.4M
239.8M
0.30% 1.49%
-21.88
3.45
-4.74% -31.15%

Financials for Teleflex

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue-0.1%2,7912,7952,8082,8172,810
Gross Profit0.2%1,5311,5291,5431,5511,550
  S&GA Expenses0.7%864858854861860
  R&D Expenses4.7%154147141137131
EBITDA-4.6%567594705853-
EBITDA Margin-4.5%0.20*0.21*0.25*0.30*-
Earnings Before Taxes-7.1%446480590566559
EBT Margin-6.9%0.16*0.17*0.21*0.20*-
Interest Expenses14.9%54.0047.0046.0051.0057.00
Net Income-12.0%363413510488485
Net Income Margin-11.9%0.13*0.15*0.18*0.17*-
Free Cahsflow-29.5%264374422538-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets2.5%6,9286,7586,7326,8736,872
  Current Assets-3.3%1,4111,4591,3851,4941,429
    Cash Equivalents-26.5%292397308467445
  Inventory9.1%579530511491478
  Net PPE5.9%447422429436444
  Goodwill3451.8%2,53771.002,4612,4932,504
Liabilities1.5%2,9062,8632,8793,0783,117
  Current Liabilities-4.8%581611610656680
  Long Term Debt-1,850----
    LT Debt, Current-110----
    LT Debt, Non Current1.9%1,6241,5941,6061,7411,740
Shareholder's Equity3.3%4,0223,8953,8533,7963,755
  Retained Earnings8.5%3,8173,518---
  Additional Paid-In Capital3.2%715693---
Accumulated Depreciation-558----
Shares Outstanding0.0%47.0047.0047.00--
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-23.2%343446489603652
  Share Based Compensation6.0%27.0026.0024.0023.0023.00
Cashflow From Investing-280.4%-259-68.20144165157
Cashflow From Financing47.7%-217-415-649-605-715
  Dividend Payments0.0%64.0064.0064.0064.0064.00

Risks for TFX

What is the probability of a big loss on TFX?

47.3%


Probability that Teleflex stock will be more than 20% underwater in next one year

44.6%


Probability that Teleflex stock will be more than 30% underwater in next one year.

12.7%


Probability that Teleflex stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does TFX drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Teleflex was unfortunately bought at previous high price.

Drawdowns

Returns for TFX

Cumulative Returns on TFX

11.5%


10-Year Cumulative Returns

6.9%


7-Year Cumulative Returns

-2.7%


5-Year Cumulative Returns

-10.5%


3-Year Cumulative Returns

What are the long-term rolling returns for TFX?

FIve years rolling returns for Teleflex.

Annualized Returns

Which funds bought or sold TFX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
added
71.00
2,416,470
4,575,470
-%
2023-03-10
MATHER GROUP, LLC.
new
-
220,174
220,174
-%
2023-03-06
Rockefeller Capital Management L.P.
added
39.49
231,000
548,000
-%
2023-02-28
Voya Investment Management LLC
added
2.92
897,835
4,158,840
0.01%
2023-02-24
SRS Capital Advisors, Inc.
added
0.2
666,114
3,425,110
0.47%
2023-02-24
NATIXIS
added
108
958,682
1,563,680
0.01%
2023-02-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
3.31
1,304,000
5,964,000
0.06%
2023-02-22
CVA Family Office, LLC
new
-
1,248
1,248
-%
2023-02-21
NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC
reduced
-15.61
15,956
366,956
0.01%
2023-02-21
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
added
0.48
21,596
104,596
-%

1–10 of 45

Latest Funds Activity

Are funds buying TFX calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own TFX
No. of Funds

Teleflex News

MarketBeat

Fulton Bank N.A. Takes $250000 Position in Teleflex Incorporated ....

MarketBeat,
20 hours ago

Seeking Alpha

Stock Traders Daily

Schedule 13G FIlings of Teleflex

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
t. rowe price investment management, inc.
18.4%
8,633,473
SC 13G/A
Feb 09, 2023
vanguard group inc
11.56%
5,420,563
SC 13G/A
Feb 06, 2023
wellington management group llp
6.59%
3,092,719
SC 13G/A
Feb 03, 2023
blackrock inc.
8.5%
3,969,361
SC 13G/A
Feb 14, 2022
price t rowe associates inc /md/
13.8%
6,494,778
SC 13G/A
Feb 10, 2022
vanguard group inc
10.81%
5,063,204
SC 13G/A
Feb 04, 2022
wellington management group llp
7.11%
3,331,136
SC 13G/A
Jan 27, 2022
blackrock inc.
10.4%
4,856,339
SC 13G/A
Jan 25, 2022
blackrock inc.
10.4%
4,856,339
SC 13G/A
Sep 10, 2021
price t rowe associates inc /md/
15.6%
7,305,896
SC 13G/A

TFX Fair Value

Teleflex fair value in different scenarios

The table shows the Fair Value estimates for Teleflex for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

-

-

-

-

-

-

-

-

-

-
Current Inflation

111.74

-51.88%

132.26

-43.05%

186.20

-19.82%

248.04

6.81%

298.42

28.51%
Very High Inflation

-

-

-

-

-

-

-

-

-

-

Historical Teleflex Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Teleflex

View All Filings
Date Filed Form Type Document
Mar 10, 2023
PRE 14A
PRE 14A
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 23, 2023
10-K
Annual Report
Feb 23, 2023
8-K
Current Report

Latest Insider Trading transactions for TFX

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-02-28
POWELL THOMAS E
acquired
-
-
2,357
executive vice president & cfo
2023-02-28
Winters James
acquired
-
-
912
corp vp, mfg and supply
2023-02-28
Kelly Liam
acquired
-
-
5,050
chairman, president & ceo
2023-02-28
Hicks Cameron P
acquired
-
-
906
corp. vp & chief hr officer
2023-02-28
Logue Daniel V.
acquired
-
-
1,139
cvp, general counsel & secty
2023-02-28
Deren John
acquired
-
-
414
corp. vp & cao
2023-02-28
White Jay
acquired
-
-
1,347
cvp & pres, global commercial
2023-02-25
White Jay
sold (taxes)
-31,749
235
-135
cvp & pres, global commercial
2023-02-25
Hicks Cameron P
sold (taxes)
-31,514
235
-134
corp. vp & chief hr officer
2023-02-25
POWELL THOMAS E
sold (taxes)
-127,468
235
-542
executive vice president & cfo

1–10 of 50

Liam J. Kelly
14000
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

TFX Income Statement

2022-12-31
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]   
Net revenues$ 2,791,041$ 2,809,563$ 2,537,156
Cost of goods sold1,259,9541,259,9611,212,282
Gross profit1,531,0871,549,6021,324,874
Selling, general and administrative expenses863,748860,085743,568
Research and development expenses153,819130,841119,747
Restructuring and impairment charges20,29921,73838,491
Gain on sale of assets and business(6,504)(91,157)0
Income from continuing operations before interest, loss on extinguishment of debt and taxes499,725628,095423,068
Interest expense54,26456,96966,494
Interest income(912)(1,328)(1,158)
Loss on extinguishment of debt45412,9860
Income from continuing operations before taxes445,919559,468357,732
Taxes on income from continuing operations83,00374,34921,931
Income from continuing operations362,916485,119335,801
Operating income (loss) from discontinued operations260331(621)
Taxes (benefit) on operating loss from discontinued operations3776(144)
Income (loss) from discontinued operations223255(477)
Net income$ 363,139$ 485,374$ 335,324
Basic:   
Income from continuing operations (in dollars per share)$ 7.74$ 10.37$ 7.22
Income (loss) from discontinued operations (in dollars per share)00.01(0.01)
Net income (in dollars per share)7.7410.387.21
Diluted:   
Income from continuing operations (in dollars per share)7.6710.237.10
Income (loss) from discontinued operations (in dollars per share)0.010(0.01)
Net income (loss), diluted (in dollar per share)$ 7.68$ 10.23$ 7.09
Weighted average shares outstanding:   
Basic (in shares)46,89846,77446,488
Diluted (in shares)47,30947,42747,287

TFX Balance Sheet

2022-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets  
Cash and cash equivalents$ 292,034$ 445,084
Accounts receivable, net408,834383,569
Inventories578,507477,643
Prepaid expenses and other current assets125,084117,277
Prepaid taxes6,5245,545
Total current assets1,410,9831,429,118
Property, plant and equipment, net447,205443,758
Operating lease assets131,211129,653
Goodwill2,536,7302,504,202
Intangibles assets, net2,306,1652,289,067
Deferred tax assets6,4026,820
Other assets89,36769,104
Total assets6,928,0636,871,722
Current liabilities  
Current borrowings87,500110,000
Accounts payable126,807118,236
Accrued expenses140,644163,441
Payroll and benefit-related liabilities133,092143,657
Accrued interest5,3325,209
Income taxes payable24,73683,943
Other current liabilities63,38155,633
Total current liabilities581,492680,119
Long-term borrowings1,624,0231,740,102
Deferred tax liabilities388,886370,124
Pension and postretirement benefit liabilities31,39445,185
Noncurrent liability for uncertain tax positions5,8058,646
Noncurrent operating lease liabilities120,437116,033
Other liabilities154,058156,765
Total liabilities2,906,0953,116,974
Commitments and contingencies
Shareholders’ equity  
Common shares, $1 par value Issued: 2022 — 47,957 shares; 2021 — 47,929 shares47,95747,929
Additional paid-in capital715,118693,090
Retained earnings3,817,3043,517,954
Accumulated other comprehensive loss(403,522)(346,959)
Shareholders equity before treasury stock, total4,176,8573,912,014
Less: Treasury stock, at cost154,889157,266
Total shareholders' equity4,021,9683,754,748
Total liabilities and shareholders' equity$ 6,928,063$ 6,871,722